Everolimus Shows Potential In Tough-to-Treat Gastric Cancer

Posted by Jeff Daas on Jan 28th, 2010 | one comment

ORLANDO – Everolimus monotherapy shows promising activity and is generally well tolerated in patients with metastatic gastric cancer who have undergone prior anticancer therapy, according to phase 2 results reported by Japanese researchers at the American Society of Clinical Oncology’s 2010 Gastrointestinal Cancers Symposium (ASCO GI)…
Read Full Article

One Response to “Everolimus Shows Potential In Tough-to-Treat Gastric Cancer”

1. Causes of stomach cancer says:

   February 1, 2010 at 2:09 am

   Stomach cancer is also called as gastric cancer. It develops in the tissues that line the stomach. Some of its symptoms are discomfort in stomach, feeling fullness even after eating small portion meal, weight loss, feeling like vomiting etc. The reason for stomach cancer is still unknown by many doctors, so if one observes the symptoms of it, should immediately consult doctor.